#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA5115061	B	Binding affinity to SARS-CoV-2 Spike trimer protein by SPR analysis	Severe acute respiratory syndrome coronavirus 2	2		single protein format	Scientific Literature
2.	ALA5115062	F	Antiviral activity against pseudovirus SARS-CoV-2 spike protein infected human HEK293T cells overexpressing ACE2 assessed as inhibition on pseudovirus infection at 10 uM incubated for 48 hrs by luciferase assay	Severe acute respiratory syndrome coronavirus 2	14		organism-based format	Scientific Literature
3.	ALA5115063	F	Antiviral activity against pseudovirus SARS-CoV-2 spike protein infected human HEK293T cells overexpressing ACE2 assessed as inhibition on pseudovirus infection at 40 uM incubated for 48 hrs by luciferase assay	Severe acute respiratory syndrome coronavirus 2	14		organism-based format	Scientific Literature
4.	ALA5115064	F	Antiviral activity against pseudovirus SARS-CoV-2 spike protein infected human HEK293T cells overexpressing ACE2 assessed as inhibition on pseudovirus infection incubated for 48 hrs by luciferase assay	Severe acute respiratory syndrome coronavirus 2	5		organism-based format	Scientific Literature
5.	ALA5115065	F	Antiviral activity against SARS-CoV-2 VSV-G pseudotyped virus infected human HEK293T cells overexpressing ACE2 incubated for 48 hrs by luciferase assay	Severe acute respiratory syndrome coronavirus 2	4		organism-based format	Scientific Literature
6.	ALA5115066	T	Cytotoxicity against human HEK293T cells overexpressing human ACE2 assessed as inhibition of cell growth incubated for 48 hrs by MTT assay	Homo sapiens	4		cell-based format	Scientific Literature
7.	ALA5115067	T	Selectivity index, ratio of CC50 for cytotoxicity against human HEK293T cells overexpressing human ACE2 to EC50 for antiviral activity against SARS-CoV-2 VSV-G pseudotyped virus infected human HEK293T cells overexpressing ACE2		4		cell-based format	Scientific Literature
8.	ALA5115068	F	Antiviral activity against SARS-CoV-2 Wuhan-HU-1 infected African green monkey Vero E6 cells preincubated for 1 hrs followed by incubation with virus 1 hr and measured after 24 hrs by fluorescence assay	Severe acute respiratory syndrome coronavirus 2	2		organism-based format	Scientific Literature
9.	ALA5115069	T	Cytotoxicity against African green monkey Vero E6 cells assessed as inhibition of cell growth incubated for 48 hrs by MTT assay	Chlorocebus sabaeus	2		cell-based format	Scientific Literature
10.	ALA5115070	T	Selectivity index, ratio of CC50 for cytotoxicity against African green monkey Vero E6 cells to EC50 for antiviral activity against SARS-CoV-2 Wuhan-Hu-1 infected African green monkey Vero E6 cells		2		cell-based format	Scientific Literature
11.	ALA5115071	F	Antiviral activity against SARS-CoV-2 Wuhan-HU-1 infected African green monkey Vero E6 cells assessed as reduction in N-protein expression at 0.55 to 15 uM by indirect immunofluorescence assay	Severe acute respiratory syndrome coronavirus 2	1		organism-based format	Scientific Literature
12.	ALA5115072	F	Antiviral activity against pseudovirus SARS-CoV-2 spike protein with E484K mutant infected human HEK293T cells overexpressing ACE2 assessed as inhibition on pseudovirus infection at 5 to 40 uM incubated for 48 hrs by luciferase assay	Severe acute respiratory syndrome coronavirus 2	1		organism-based format	Scientific Literature
13.	ALA5115073	F	Antiviral activity against pseudovirus SARS-CoV-2 spike protein with D614G mutant infected human HEK293T cells overexpressing ACE2 assessed as inhibition on pseudovirus infection at 5 to 40 uM incubated for 48 hrs by luciferase assay	Severe acute respiratory syndrome coronavirus 2	1		organism-based format	Scientific Literature
14.	ALA5115074	F	Antiviral activity against pseudovirus SARS-CoV-2 spike protein with N501Y mutant infected human HEK293T cells overexpressing ACE2 assessed as inhibition on pseudovirus infection at 5 to 40 uM incubated for 48 hrs by luciferase assay	Severe acute respiratory syndrome coronavirus 2	1		organism-based format	Scientific Literature
15.	ALA5115075	F	Antiviral activity against pseudotyped spike protein mutant B.1.1.7 SARS-CoV-2 Alpha variant infected human HEK293T cells overexpressing ACE2 assessed as inhibition on viral entry incubated for 48 hrs by luciferase assay	Severe acute respiratory syndrome coronavirus 2	1		organism-based format	Scientific Literature
16.	ALA5115076	F	Antiviral activity against pseudotyped spike protein mutant B.1.351 SARS-CoV-2 Beta variant infected human HEK293T cells overexpressing ACE2 assessed as inhibition on viral entry incubated for 48 hrs by luciferase assay	Severe acute respiratory syndrome coronavirus 2	1		organism-based format	Scientific Literature
17.	ALA5115077	F	Antiviral activity against pseudotyped spike protein mutant P.10 SARS-CoV-2 Gamma variant infected human HEK293T cells overexpressing ACE2 assessed as inhibition on viral entry incubated for 48 hrs by luciferase assay	Severe acute respiratory syndrome coronavirus 2	1		organism-based format	Scientific Literature
18.	ALA5115078	F	Antiviral activity against pseudovirus spike protein mutant B.1.617.2 SARS-CoV-2 Delta variant infected human HEK293T cells overexpressing ACE2 assessed as inhibition on viral entry incubated for 48 hrs by luciferase assay	Severe acute respiratory syndrome coronavirus 2	1		organism-based format	Scientific Literature
19.	ALA5115079	F	Antiviral activity against pseudovirus SARS-CoV-2 spike protein mutant Omicron variant infected human HEK293T cells overexpressing ACE2 assessed as inhibition on viral entry incubated for 48 hrs by luciferase assay	Severe acute respiratory syndrome coronavirus 2	1		organism-based format	Scientific Literature
20.	ALA5115080	B	Binding affinity to SARS-CoV-2 Spike protein S1 subunit assessed as blockage of receptor-binding domain S1 subunit interaction with human ACE2 in human HEK293T cells by Co-IP/western blot analysis	Severe acute respiratory syndrome coronavirus 2	1		cell-based format	Scientific Literature